Improved translation efficiency of therapeutic mRNA

Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129 · see citing works

Direct Gene Transfer into Mouse Muscle in Vivo

Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173 · see citing works

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., & Fujita, T. (2004) · Nature Immunology · doi:10.1038/ni1087 · Cited by 3,935 · see citing works

Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets

Sonenberg, N., & Hinnebusch, A. G. (2009) · Cell · doi:10.1016/j.cell.2009.01.042 · Cited by 3,304 · see citing works

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA

Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662 · see citing works

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.-L., Fraser, C. C., Cavazzana-Calvo, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejm200301163480314 · Cited by 1,867 · see citing works

Shared and Unique Functions of the DExD/H-Box Helicases RIG-I, MDA5, and LGP2 in Antiviral Innate Immunity

Yoneyama, M., Kikuchi, M., Matsumoto, K., Imaizumi, T., Miyagishi, M., Taira, K., Foy, E. M., Loo, Y., Gale, M., Akira, S., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.2851 · Cited by 1,691 · see citing works

mRNA is an endogenous ligand for toll-like receptor 3

Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310175200 · Cited by 1,062 · see citing works

Functional 5′ UTR mRNA structures in eukaryotic translation regulation and how to find them

Leppek, K., Das, R., & Barna, M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.103 · Cited by 949 · see citing works

Generation of Destabilized Green Fluorescent Protein as a Transcription Reporter

Li, X., Zhao, X., Fang, Y., Jiang, X., Duong, T., Fan, C., Huang, C.-C., & Kain, S. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.34970 · Cited by 846 · see citing works

Influences of mRNA secondary structure on initiation by eukaryotic ribosomes.

Kozak, M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2850 · Cited by 687 · see citing works

Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation

Anderson, B. R., Muramatsu, H., Nallagatla, S. R., Bevilacqua, P. C., Sansing, L. H., Weissman, D., & Karikó, K. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq347 · Cited by 682 · see citing works

Structural Basis for dsRNA Recognition, Filament Formation, and Antiviral Signal Activation by MDA5

Wu, B., Peisley, A., Richards, C., Yao, H., Zeng, X., Lin, C., Feixia Chu, C., Walz, T., & Hur, S. (2012) · Cell · doi:10.1016/j.cell.2012.11.048 · Cited by 572 · see citing works

Point mutations close to the AUG initiator codon affect the efficiency of translation of rat preproinsulin in vivo

Kozak, M. (1984) · Nature · doi:10.1038/308241a0 · Cited by 538 · see citing works

Essential Role for the dsRNA-Dependent Protein Kinase PKR in Innate Immunity to Viral Infection

Balachandran, S., Roberts, P. C., Brown, L. E., Truong, H., Pattnaik, A. K., Archer, D. R., & Barber, G. N. (2000) · Immunity · doi:10.1016/s1074-7613(00)00014-5 · Cited by 527 · see citing works

The role of the 5′ untranslated region of an mRNA in translation regulation during development

van der Velden, A. W., & Thomas, A. A. M. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00134-4 · Cited by 397 · see citing works

How cells get the message: dynamic assembly and function of mRNA–protein complexes

Müller-McNicoll, M., & Neugebauer, K. M. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3434 · Cited by 397 · see citing works

Control of mammalian translation by mRNA structure near caps

Babendure, J. R., Babendure, J. L., Ding, J.-H., & Tsien, R. Y. (2006) · RNA · doi:10.1261/rna.2309906 · Cited by 339 · see citing works

Identification of RNA Sequence Motifs Stimulating Sequence-Specific TLR8-Dependent Immune Responses

Forsbach, A., Némorin, J.-G., Montino, C., Müller, C., Samulowitz, U., Vicari, A. P., Jurk, M., Mutwiri, G., Krieg, A. Μ., Lipford, G. B., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3729 · Cited by 316 · see citing works

5′-UTR G-quadruplex structures acting as translational repressors

Beaudoin, J.-D., & Perreault, J.-P. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq557 · Cited by 255 · see citing works

Control of mammalian gene expression by selective mRNA export

Wickramasinghe, V. O., & Laskey, R. A. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4010 · Cited by 230 · see citing works

5’-triphosphate-dependent activation of PKR by RNAs with short stem-loops

Nallagatla, S. R., Hwang, J., Toroney, R., Zheng, X., Cameron, C. E., & Bevilacqua, P. C. (2007) · Science · doi:10.1126/science.1147347 · Cited by 222 · see citing works

Spatial and temporal control of RNA stability

Bashirullah, A., Cooperstock, R. L., & Lipshitz, H. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111145698 · Cited by 202 · see citing works

Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy.

Wang, Y.-H., Su, H.-H., Yang, Y., Hu, Y.-X., Zhang, L., Blancafort, P., & Huang, L. (2013) · Molecular Therapy · doi:10.1038/mt.2012.250 · Cited by 189 · see citing works

Structural basis for cytosolic double-stranded RNA surveillance by human oligoadenylate synthetase 1

Donovan, J., Dufner, M., & Korennykh, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218528110 · Cited by 163 · see citing works

Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells

Zou, S., Scarfo, K. A., Nantz, M. H., & Hecker, J. G. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.01.019 · Cited by 161 · see citing works

Half-lives of beta and gamma globin messenger RNAs and of protein synthetic capacity in cultured human reticulocytes

Ross, J., & Sullivan, T. (1985) · Blood · doi:10.1182/blood.v66.5.1149.1149 · Cited by 121 · see citing works

Optimization of mRNA untranslated regions for improved expression of therapeutic mRNA

Asrani, K. H., Farelli, J. D., Stahley, M. R., Miller, R. L., Cheng, C. J., Subramanian, R. R., & Brown, J. M. (2018) · RNA Biology · doi:10.1080/15476286.2018.1450054 · Cited by 111 · see citing works

Stability of globin mRNA in terminally differentiating murine erythroleukemia cells

Volloch, V., & Housman, D. E. (1981) · Cell · doi:10.1016/0092-8674(81)90146-x · Cited by 108 · see citing works

Features in the 5′ non-coding sequences of rabbit α and β-globin mRNAs that affect translational efficiency

Kozak, M. (1994) · Journal of Molecular Biology · doi:10.1016/s0022-2836(05)80019-1 · Cited by 101 · see citing works

The stability of human beta-globin mRNA is dependent on structural determinants positioned within its 3' untranslated region

RUSSELL, J. P., & Liebhaber, S. (1996) · Blood · doi:10.1182/blood.v87.12.5314.bloodjournal87125314 · Cited by 70 · see citing works

RNA-Based Tools for Nuclear Reprogramming and Lineage-Conversion: Towards Clinical Applications

Bernal, J. A. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9494-8 · Cited by 65 · see citing works

Fast production of homogeneous recombinant RNA—towards large-scale production of RNA

Nelissen, F. H. T., Leunissen, E. H. P., van de Laar, L., Tessari, M., Heus, H. A., & Wijmenga, S. S. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks292 · Cited by 65 · see citing works

RNA pseudoknots and the regulation of protein synthesis

Brierley, I., Gilbert, R. J. C., & Pennell, S. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360684 · Cited by 58 · see citing works

Generation of human induced pluripotent stem cells using non-synthetic mRNA

Rohani, L., Fabian, C., Holland, H., Naaldijk, Y., Dressel, R., Loeffler‐Wirth, H., Binder, H., Arnold, A., & Stolzing, A. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.03.008 · Cited by 36 · see citing works

Preparation of Short RNA by In Vitro Transcription

Lu, C. C., & Li, P. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-113-4_5 · Cited by 10 · see citing works

mRNA-based therapeutics: powerful and versatile tools to combat diseases

Qin, S., Tang, X., Chen, Y., Chen, K., Fan, N., Xiao, W., Zheng, Q., Li, G., Teng, Y., Wu, M., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01007-w · Cited by 801 · see citing works

Advances in COVID-19 mRNA vaccine development

Fang, E., Liu, X., Li, M., Zhang, Z., Song, L., Zhu, B., Wu, X., Liu, J., Zhao, D., & Li, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00950-y · Cited by 601 · see citing works

mRNA-based cancer therapeutics

Liu, C., Shi, Q., Huang, X., Koo, S., Kong, N., & Tao, W. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00586-2 · Cited by 500 · see citing works

An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development

Wang, F., Kream, R. M., & Stefano, G. B. (2020) · Medical Science Monitor · doi:10.12659/msm.924700 · Cited by 243 · see citing works

Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives

Gómez-Aguado, I., Rodríguez-Castejón, J., Vicente-Pascual, M., Rodríguez‐Gascón, A., Solinís, M. Á., & del Pozo‐Rodríguez, A. (2020) · Nanomaterials · doi:10.3390/nano10020364 · Cited by 224 · see citing works

Research Advances on the Stability of mRNA Vaccines

Cheng, F., Wang, Y., Bai, Y., Liang, Z., Mao, Q., Liu, D., Wu, X., & Xu, M. (2023) · Viruses · doi:10.3390/v15030668 · Cited by 171 · see citing works

Nucleic acid degradation as barrier to gene delivery: a guide to understand and overcome nuclease activity

Zhang, H., Vandesompele, J., Braeckmans, K., Smedt, S. C. D., & Remaut, K. (2023) · Chemical Society Reviews · doi:10.1039/d3cs00194f · Cited by 140 · see citing works

mRNA vaccines for COVID-19 and diverse diseases

Hussain, A., Yang, H., Zhang, M., Liu, Q., Alotaibi, G., Irfan, M. F., He, H., Chang, J. K., Liang, X., Weng, Y., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.032 · Cited by 117 · see citing works

Recent Advances and Challenges in Gene Delivery Mediated by Polyester-Based Nanoparticles

Piperno, A., Sciortino, M. T., Giusto, E., Montesi, M., Panseri, S., & Scala, A. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s321329 · Cited by 97 · see citing works

Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the Vaccine Development Arena

Chavda, V. P., Hossain, M. M. M., Beladiya, J., & Apostolopoulos, V. (2021) · Biologics · doi:10.3390/biologics1030020 · Cited by 92 · see citing works

Role of NAT10-mediated ac4C-modified HSP90AA1 RNA acetylation in ER stress-mediated metastasis and lenvatinib resistance in hepatocellular carcinoma

Pan, Z., Bao, Y., Hu, M., Zhu, Y., Tan, C., Fan, L., Yu, H., Wang, A., Cui, J., & Sun, G. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01355-8 · Cited by 84 · see citing works

mRNA vaccine sequence and structure design and optimization: Advances and challenges

Jin, L., Zhou, Y., Zhang, S., & Chen, S. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108015 · Cited by 85 · see citing works

Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development

Schmidt, C., & Schnierle, B. S. (2023) · Pathogens · doi:10.3390/pathogens12010138 · Cited by 78 · see citing works

Perkembangan Teknologi Terkini dalam Mempercepat Produksi Vaksin COVID-19

Sari, I. P., & Sriwidodo, S. (2020) · Majalah Farmasetika · doi:10.24198/mfarmasetika.v5i5.28082 · Cited by 70 · see citing works

mRNA-Based Therapeutics in Cancer Treatment

Sun, H., Zhang, Y., Wang, G., Yang, W., & Xu, Y. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020622 · Cited by 63 · see citing works

mRNA therapies: Pioneering a new era in rare genetic disease treatment

Shen, G., Liu, J., Yang, H., Xie, N., & Yang, Y. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.03.056 · Cited by 61 · see citing works

A single-dose circular RNA vaccine prevents Zika virus infection without enhancing dengue severity in mice

Liu, X., Li, Z., Li, X., Wu, W., Jiang, H., Zheng, Y., Zhou, J., Ye, X., Lu, J., Wang, W., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53242-0 · Cited by 57 · see citing works

Nucleic acid-based therapy for coronavirus disease 2019

Piyush, R., Rajarshi, K., Chatterjee, A., Khan, R., & Ray, S. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05007 · Cited by 42 · see citing works

Vaccines platforms and COVID-19: what you need to know

Acosta-Coley, I., Cervantes-Ceballos, L., Benítez, L. P. T., Sierra-Marquez, L., Cabarcas-Montalvo, M., Espiñeira, M. C. G., Coronell-Rodríguez, W., & Arroyo-Salgado, B. (2022) · Tropical Diseases Travel Medicine and Vaccines · doi:10.1186/s40794-022-00176-4 · Cited by 40 · see citing works

Promising RNA-based cancer gene therapy using extracellular vesicles for drug delivery

Xue, V. W., Wong, S. C. C., Song, G., & Cho, W. C. S. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1738377 · Cited by 37 · see citing works

Recent Advances and Innovations in the Preparation and Purification of In Vitro-Transcribed-mRNA-Based Molecules

Zhang, J., Liu, Y., Li, C., Xiao, Q., Zhang, D., Chen, Y., Rosenecker, J., Ding, X., & Guan, S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092182 · Cited by 39 · see citing works

Synthesis of cationic quaternized pullulan derivatives for miRNA delivery

Moraes, F. C., Antunes, J. C., Ramirez, L. M. F., Aprile, P., Franck, G., Chauvierre, C., Chaubet, F., & Letourneur, D. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119041 · Cited by 35 · see citing works

The Current Landscape of mRNA Vaccines Against Viruses and Cancer–A Mini Review

Ladak, R. J., He, A. J., Huang, Y.-H., & Ding, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.885371 · Cited by 33 · see citing works

mRNA therapeutics: Transforming medicine through innovation in design, delivery, and disease treatment

Ige, M. A., Ren, X., Yang, Y., Zhang, H., Shen, C., Jiang, Y., Li, J., & Wan, X. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102721 · Cited by 29 · see citing works

A single-nucleotide resolution capillary gel electrophoresis workflow for poly(A) tail characterization in the development of mRNA therapeutics and vaccines

Grandi, D. D., Dayeh, D. M., Kaur, K., Chen, Y., Henderson, S., Moon, Y., Bhowmick, A., Ihnat, P. M., Fu, Y., Muthusamy, K., et al. (2023) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2023.115692 · Cited by 24 · see citing works

Nanoparticle-based delivery platforms for mRNA vaccine development

Okay, S., Özcan, Ö. Ö., & Karahan, M. (2020) · AIMS Biophysics · doi:10.3934/biophy.2020023 · Cited by 23 · see citing works

mRNA delivery technologies: Toward clinical translation

Gómez-Aguado, I., Rodríguez-Castejón, J., Beraza-Millor, M., Rodríguez‐Gascón, A., del Pozo‐Rodríguez, A., & Solinís, M. Á. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.04.010 · Cited by 23 · see citing works

Optimizing mRNA translation efficiency through rational 5′UTR and 3′UTR combinatorial design

Li, T., Liu, G., Bu, G., Xu, Y., He, C., & Zhao, G. (2025) · Gene · doi:10.1016/j.gene.2025.149254 · Cited by 23 · see citing works

Neoantigen-specific mRNA/DC vaccines for effective anticancer immunotherapy

Zhang, W., Guan, J., Wang, W., Chen, G., Li, F., & Lu, Z. (2024) · Genes and Immunity · doi:10.1038/s41435-024-00305-3 · Cited by 18 · see citing works

Optimal Chimeric Antigen Receptor (CAR)-mRNA for Transient CAR T Cell Generation

Kitte, R., Serfling, R., Blache, U., Seitz, C., Schrader, S., Koehl, U., Fricke, S., Bär, C., & Tretbar, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030965 · Cited by 18 · see citing works

Revolutionizing viral disease vaccination: the promising clinical advancements of non-replicating mRNA vaccines

Guo, X., Liu, D., Huang, Y., Deng, Y., Wang, Y., Mao, J., Zhou, Y., Xiong, Y., & Gao, X. (2023) · Virology Journal · doi:10.1186/s12985-023-02023-0 · Cited by 17 · see citing works

Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines

Szczepanek, J., Skorupa, M., Goroncy, A., Jarkiewicz‐Tretyn, J., Wypych, A., Sandomierz, D., Jarkiewicz-Tretyn, A., Dejewska, J., Ciechanowska, K., Pałgan, K., et al. (2022) · Vaccines · doi:10.3390/vaccines10010099 · Cited by 16 · see citing works

A brief review of mRNA therapeutics and delivery for bone tissue engineering

Rajendran, A. K., Amirthalingam, S., & Hwang, N. S.-Y. (2022) · RSC Advances · doi:10.1039/d2ra00713d · Cited by 16 · see citing works

Non-viral delivery of RNA for therapeutic T cell engineering

Berdecka, D., Smedt, S. C. D., Vos, W. H. D., & Braeckmans, K. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115215 · Cited by 14 · see citing works

Trinucleotide cap analogs with triphosphate chain modifications: synthesis, properties, and evaluation as mRNA capping reagents

Warmiński, M., Depaix, A., Ziemkiewicz, K., Śpiewla, T., Zuberek, J., Drążkowska, K., Kędzierska, H., Popielec, A., Baranowski, M. R., Sklucka, M., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae763 · Cited by 12 · see citing works

Metal organic frameworks (MOFS) as non-viral carriers for DNA and RNA delivery: a review

Soriano-Giles, G., Giles-Mazón, E. A., López, N., Reinheimer, E. W., Varela-Guerrero, V., & Ballesteros‐Rivas, M. (2022) · Reviews in Inorganic Chemistry · doi:10.1515/revic-2022-0004 · Cited by 12 · see citing works

Research progress of mRNA vaccines for infectious diseases

Zhang, Z., Du, J., Zhang, D., Han, R., Wu, X., & Liang, Y. (2025) · European journal of medical research · doi:10.1186/s40001-025-03060-x · Cited by 16 · see citing works

mRNA Vaccines in Modern Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)—A Comprehensive Literature Review with Focus on Current Clinical Trials

Kabut, J., Stępień, G. J., Furgoł, T., Miciak, M., Nafalska, N., Stopyra, M., Jezierzański, M. M., Feret, K., & Gisterek, I. (2025) · Biomedicines · doi:10.3390/biomedicines13092187 · Cited by 10 · see citing works

Therapeutic Application of mRNA for Genetic Diseases

Schürmann, P. J. L., Vriesman, S. V. B., Castro-Alpízar, J., Kooijmans, S. A. A., Nieuwenhuis, E. E. S., Schiffelers, R. M., & Fuchs, S. A. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70019 · Cited by 9 · see citing works

Understanding the regulation of protein synthesis under stress conditions

Irshad, I. U., & Sharma, A. K. (2024) · Biophysical Journal · doi:10.1016/j.bpj.2024.09.014 · Cited by 7 · see citing works

Optimization of extended Kozak elements enhances recombinant proteins expression in CHO cells

Li, Z.-M., Lin, Y., Luo, C.-H., Sun, Q.-L., Mi, C., Wang, X., & Wang, T.-Y. (2024) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2024.06.020 · Cited by 7 · see citing works

An immunoinformatics approach in designing high-coverage mRNA multi-epitope vaccine against multivariant SARS-CoV-2

Giri-Rachman, E. A., Kurnianti, A. M. F., Rizarullah, R., Setyadi, A. H., Artarini, A., Tan, M. I., Riani, C., Natalia, D., Aditama, R., & Nugrahapraja, H. (2025) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2025.100524 · Cited by 9 · see citing works

Protective effects of a novel chimeric virus–like particle vaccine against virulent NDV and IBDV challenge

Li, J., Ding, J., Chen, K., Xu, X., Shao, Y., Zhang, D., Yu, X., Guo, C., Qian, J., & Ding, Z. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.11.062 · Cited by 6 · see citing works

Lipid nanoparticle-assisted mRNA therapy for cancer treatment

Kim, H.-J., Le, N. D., Oh, H.-J., Kim, B., Yoo, E., Kim, J., & Yim, H. (2025) · Applied Physics Reviews · doi:10.1063/5.0247029 · Cited by 5 · see citing works

The stability landscape of mRNA vaccines: challenges and mitigation strategies

Zhong, L., Tao, L., Zhai, Z., Liao, L., Shi, C., Yao, S., & Liu, X. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128515 · Cited by 6 · see citing works

Targeting Precision in Cancer Immunotherapy: Naturally-Occurring Antigen-Specific TCR Discovery with Single-Cell Sequencing

Alrhmoun, S., Fisher, M. S., Lopatnikova, J., Perik-Zavodskaia, O., Volynets, M., Perik-Zavodskii, R., Shevchenko, J. A., Вячеславович, Н. К., Philippova, J., Alsalloum, A., et al. (2024) · Cancers · doi:10.3390/cancers16234020 · Cited by 5 · see citing works

Combined therapy with pioglitazone and FGF21 mRNA synergistically ameliorates metabolic disorders in NAFLD rats

Huang, X., Xia, Z., Huang, Y., Sun, Y., Zhang, L., Xiong, W., & Zhang, Z. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15146 · Cited by 5 · see citing works

Navigating molecular therapies: The emerging role of mRNA in treating inherited metabolic diseases

Castro-Alpízar, J., Lenderink, M. J., Nieuwenhuis, E. E. S., Kooijmans, S. A. A., & Fuchs, S. A. (2025) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2025.109698 · Cited by 4 · see citing works

Vaccine Development Against SARS-CoV-2: From Virology to Vaccine Clinical Trials

Kardani, K., & Bolhassani, A. (2020) · Coronaviruses · doi:10.2174/2666796701999201026205553 · Cited by 4 · see citing works

Non-viral delivery of genome-editing tools for treatment of genetic disorders

Yang, J., Chen, Y., Chen, X., & Ping, Y. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.02.014 · Cited by 3 · see citing works

Delving into revolutionary SARS-CoV-2 vaccine approaches: Molecular and virological examinations; principles of SARS-CoV-2 vaccine platform

Edalat, F., Hosseini, F., Moattari, A., Letafati, A., Sarvari, J., & Hosseini, S. Y. (2023) · Vacunas · doi:10.1016/j.vacun.2023.08.002 · Cited by 3 · see citing works

Canine adipose tissue-derived MSCs engineered with mRNA to overexpress TSG-6 and enhance the anti-inflammatory effects in canine macrophages

Yun, G.-H., Park, S., Lim, G., Seo, K., & Youn, H. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1134185 · Cited by 3 · see citing works

The Evolving Landscape of mRNA Therapeutics: From Molecular Design and Advanced Delivery Systems to Clinical Translation and Future Vistas

Sadaqa, E., Fajriawan, A. A., & Muttaqien, S. E. (2026) · Biointerface Research in Applied Chemistry · doi:10.33263/briac161.028 · Cited by 2 · see citing works

Immune-related therapeutics: an update on antiviral drugs and vaccines to tackle the COVID-19 pandemic

Mir, I., Aamir, S., Shah, S. R. H., Shahid, M., Amin, I., Afzal, S., Nawaz, A., Khan, M. U., & Idrees, M. (2022) · Osong Public Health and Research Perspectives · doi:10.24171/j.phrp.2022.0024 · Cited by 2 · see citing works

A genetic variant in the CD40 gene is related to HBV infection in the Chinese Han population

Wu, W., Xu, S., Zeng, Y., Yu, L., Chen, T., Shang, H., Liu, C., Yang, B., & Ou, Q. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000331 · Cited by 1 · see citing works

Delving into revolutionary SARS-CoV-2 vaccine approaches: Molecular and virological examinations; principles of SARS-CoV-2 vaccine platform

Edalat, F., Tabatabaie, F. H., Moattari, A., Letafati, A., Sarvari, J., & Hosseini, S. Y. (2024) · Vacunas (English Edition) · doi:10.1016/j.vacune.2024.02.013 · Cited by 1 · see citing works

mRNA-based immunotherapy platform targeting endometrial cancer

Freyberg, M., Dierks, M., Naß, N., George, C., Geffken, M., Ignatov, A., Kalinski, T., & Ignatova, Z. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07497-w · Cited by 1 · see citing works

Application of quantitative and engineering biology in mRNA gene therapy

Xiang, H., Ke, L., Yang, X., Guo, J., Yang, W., & Hu, Y. (2020) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2020-0476 · Cited by 1 · see citing works

An Overview of the Progress Made on the Coronavirus Vaccine

Fang, Y. (2020) · E3S Web of Conferences · doi:10.1051/e3sconf/202018503042

Vaccines’ Candidates Against SARS-CoV-2

ISI-SENAI-CIMATEC Group (2020) · Journal of Bioengineering, Technologies and Health · doi:10.34178/jbth.v3i2.126

mRNA vaccines: a promising solution for incurable diseases

Ge, H., Hei, Y., & Wu, J. (2024) · International Conference on Biological Engineering and Medical Science (ICBioMed) · doi:10.1117/12.3021657

Research Progress on mRNA Based Protein Replacement Therapy for Inborn Errors of Metabolism

李, 京. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.154899

Targeting Ocular Tissue through Surface-Modified and Multifunctional Biomaterials and mRNA-Based Therapeutics

Okur, N. Ü., Okur, M. E., Bülbül, E. Ö., Miliotou, Α. N., Karantas, I. D., & Siafaka, P. I. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128373593250619074556

The strategies and advances of mRNA translation booster

Shi, Y., Sun, K., Hu, Y., Lou, Z., Wang, Y., & You, J. (2025) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2025.101090

Minimal Polymerase-Containing Precursor Required for Chikungunya Virus RNA Synthesis

Aponte-Diaz, D., Jain, A., Harris, J. M., Arnold, J. J., & Cameron, C. E. (2025) · Viruses · doi:10.3390/v17121556

Combination gene therapy with AAV based RPE65 and survivin vectors sustains phenotypic rescue in neural retina of LCA2 mice

Singh, V., Huda, S., Kumar, G. N., & Jayandharan, G. R. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05485-2

Development of polysaccharide-based nanoparticles for miRNA delivery

Moraes, F. C. (2021) · doi:10.70675/804cca6fzc804z465dz9ee8z375e04ed941f

Nucleoside Modifications and Poly(A) Tail Length Greatly Influence Protein Expression from In Vitro-Transcribed mRNA in a Salmonid Cell Line

Krog, T. F., Haukland, I. S., & Haugland, G. T. (2026) · Vaccines · doi:10.3390/vaccines14050367

A novel in silico construction of a DNA vaccine expressing broad-spectrum CD8 T-cell multi-epitope antigen against high-risk human papillomavirus infection

Pereira, G. O., Invenção, M. D. C. V., & Batista, M. V. D. A. (2026) · Vaccine X · doi:10.1016/j.jvacx.2026.100827

Partial base pairing between 5′ and 3′ UTRs artificially regulates IVT mRNA expression levels

Hosoda, N., Takasu, A., Nakanishi, K., Hayashi, K., Saito, S., Yamada, N., & Tsuge, K. (2026) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2026.2698790

ppLM-CO: Parameter-Efficient Codon Optimization with Frozen Pre-trained Protein Language Model and Guaranteed Translation Fidelity

Pathak, S., & Lin, G. (2026) · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB) · doi:10.1145/3807503.3819445

Next-generation CAR therapies enabled by mRNA engineering and delivery

Zhao, Q., Wen, Q., Pu, P., Xu, C., Hu, Q., Zhou, Z., Hua, X., & Zhang, X. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.09.001

Enhancing Stability of Destabilized Green Fluorescent Protein Using Chimeric mRNA Containing Human Beta-Globin 5' and 3' Untranslated Regions.

Adibzadeh, S., Fardaei, M., Takhshid, M. A., Miri, M. R., Dehbidi, G. R., Farhadi, A., Ranjbaran, R., Alavi, P., Nikouyan, N., Seyyedi, N., et al. (2019) · Europe PMC (PubMed Central) · Cited by 20 · see citing works

Synthetic mRNAs with Superior Translation and Stability Properties

Grudzien‐Nogalska, E., Kowalska, J., Su, W., Kuhn, A. N., Slepenkov, S. V., Darżynkiewicz, E., Şahin, U., Jemielity, J., & Rhoads, R. E. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-260-5_4 · Cited by 59 · see citing works

Research progress in mRNA drug modification and delivery systems

Zhou, Z., & Li, X. (2023) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2023-0101 · Cited by 3 · see citing works

Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency

Kim, S. C., Sekhon, S. S., Shin, W.-R., Ahn, G., Cho, B.-K., Ahn, J.-Y., & Kim, Y.-H. (2022) · Molecular & Cellular Toxicology · doi:10.1007/s13273-021-00171-4 · Cited by 255 · see citing works

Chemically modified tRNA enhances the translation capacity of mRNA rich in cognate codons

Dong, L., Wang, J., & Xia, Q. (2025) · Nature Communications · doi:10.1038/s41467-025-62981-7 · Cited by 6 · see citing works